                         SEQUENCE LISTING

<110>  ProQR Therapeutics II B.V.
 
<120>  CHEMICALLY MODIFIED OLIGONUCLEOTIDES FOR RNA EDITING

<130>  P3670PC00

<160>  13    

<170>  PatentIn version 3.5

<210>  1
<211>  61
<212>  DNA
<213>  Mus musculus

<400>  1
uguuggaugg agaacaacuc uaggcagagg ucucaaaggc uggggcugug uuggacagca       60

a                                                                       61


<210>  2
<211>  39
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  AON: ADAR102-1; ADAR102-13

<400>  2
cacagcccca gccuuugaga ccucugucca gaguuguuc                              39


<210>  3
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IDUA125; IDUA163; IDUA170; IDUA176; IDUA182; IDUA247; IDUA250; 
       IDUA253; IDUA103; IDUA268

<400>  3
gccccagccu uugagaccuc uguccagagu uguucu                                 36


<210>  4
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  4
ctcacagtca tggggctc                                                     18


<210>  5
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  primer

<400>  5
cactgtatga ttgctgtcca ac                                                22


<210>  6
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Wild type probe (FAM NFQ labeled)

<400>  6
agaacaactc tgggcagagg tctca                                             25


<210>  7
<211>  25
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Mutant probe (HEX NFQ labeled)

<400>  7
agaacaactc taggcagagg tctca                                             25


<210>  8
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  target RNA-specific primer

<400>  8
ggaaacgtag gttggggtgt g                                                 21


<210>  9
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Pyroseq Fwd2 IDUA primer

<400>  9
agtactcaca gtcatggggc tca                                               23


<210>  10
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Pyroseq Rev2 IDUA Biotin

<400>  10
gccaggacac ccactgtatg at                                                22


<210>  11
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  IDUA-Seq2 primer

<400>  11
tggggctcat ggccct                                                       16


<210>  12
<211>  48
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  pyrosequencing analysis sequence

<400>  12
gttggatgga gaacaactct agggcagagg tctcaagagg ctggggct                    48


<210>  13
<211>  38
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  dispensation order

<400>  13
cgtgatgaga cactcgtagc agagtctgca gagctgca                               38


